MYOM2 and Miyoshi myopathy: It was reported that expanded T-cell clones in MM patients were associated with longer survival and that most very long-term survivors without relapse had low levels of M-protein, suggesting that T-cell immunity plays a crucial role in inhibiting MM disease progression, similar to immunogenic tumors [14,15].